Oxford BioMedica (GB:OXB) has released an update.
Oxford Biomedica PLC has notified that BlackRock, Inc. now holds less than 5% of both direct and indirect voting rights following a recent change. BlackRock’s previous notification indicated a combined total of over 5% in voting rights, highlighting a reduction in their stake. The adjustment in BlackRock’s holdings crossed the threshold on June 19, 2024, and Oxford Biomedica was informed on June 21, 2024.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
